Pioneering Neurosurgeon Bob Carter, MD, PhD, Joins UC San Diego Health Sciences

 

March 09, 2010  |  

Surgeon-scientist launches comprehensive center for surgical treatment of brain disease  

Distinguished neurosurgeon and scientist, Bob Carter, MD, PhD, has been named chief of the division of neurosurgery at UC San Diego

Bob Carter

Bob Carter, MD, PhD

Medical Center and the Moores UCSD Cancer Center.  Under his leadership, the university will launch a multidisciplinary Brain Tumor Treatment Center that will serve as a destination for patients and referring physicians seeking integrated care from multiple specialists in one location.     

Internationally recognized for advancing novel therapies for the treatment of glioblastomas at both the genetic and surgical level, Carter was one of the first researchers to identify a genetic signature for brain tumors in blood samples of cancer patients. This form of profiling enables the early diagnosis and personalized treatment of brain tumors. Carter is also a leader in immunotherapy, researching how the body’s own biologic system can be used to reject cancerous growths.  

“Dr. Carter is one of the nations most sought after neurosurgeons for the treatment of complex neurological disease,” said Mark A. Talamini, MD, professor and M. J. Orloff Family Chair of the department of surgery at UC San Diego Medical Center. “Our region is fortunate to have one of the world’s preeminent brain surgeons to enrich and expand California’s health sciences innovation platform.”  

Carter arrived from Massachusetts General Hospital and Harvard Medical School where he specialized in surgical treatment of  brain and skull base tumors, brain aneurysms, and other intracranial neurologic diseases. Carter obtained his MD and PhD degrees at the Johns Hopkins University School of Medicine and Public Health respectively.  His post-doctoral training included residency in neurosurgery at Massachusetts General Hospital and post-doctoral fellowships at the Whitehead Institute, Cambridge, MA and Children’s Hospital, Boston.   

“UC San Diego Medical Center has a patient-focused vision of how to treat all forms of neurological disease from diagnosis and imaging to surgery and rehabilitation,” said Carter, professor and chief of neurosurgery at UC San Diego Medical Center. “UC San Diego has an amazing trajectory in terms of innovation and growth. The UCSD Division of Neurosurgery will continue to increase its slope and acceleration forward.”  

Carter will lead UCSD Medical Centers effort to develop a specialized ICU for neurological patients, offering rapid assessment and treatment of complex neurological illnesses including stroke, brain hemorrhage, traumatic brain injury, coma, and neurological infections. Advanced technologies and procedures include new endovascular therapies, awake surgery for brain tumors to preserve limb and speech function, functional brain mapping, and deep brain stimulation.  

Carter is internationally recognized for his contributions to the neurosurgical field.  He serves on the editorial boards for the journal Neurosurgery and serves on the program committee for the International Stroke Conference.    

Carter will lead a team of 21 neurosurgeons including 11 neurosurgeons training in the San Diegos only neurosurgical residency program. Areas of expertise include treatment of arteriovenous malformations, brain malignancies, carotid artery disease, cerebral aneurysms, chronic pain, epilepsy, movement disorders, minimally invasive spine surgery and Parkinson’s disease. 

# # #

Media Contact: Jackie Carr, 619-543-6163, jcarr@ucsd.edu

 




Media Contact

Share This Article


Related News

2/13/2018
Researchers at University of California San Diego School of Medicine and Shiley Eye Institute at UC San Diego Health have discovered that a chemical compound that activates ATF6, a gene associated wit ...
2/8/2018
Ever wonder why obese bodies burn less calories or why dieting often leads to a plateau in weight loss? In both cases the body is trying to defend its weight by regulating energy expenditure. In a pap ...
2/7/2018
Treating obese mice with catestatin (CST), a peptide naturally occurring in the body, showed significant improvement in glucose and insulin tolerance and reduced body weight, report University of Cali ...
2/6/2018
Researchers at University of California San Diego School of Medicine found a significant number of children across four regions in the United States were determined to have fetal alcohol spectrum diso ...



Follow Us